Medical morbidity and risk of general hospital admission associated with concurrent anorexia nervosa and COVID-19: An observational study.
COVID-19
SARS-CoV-2
anorexia nervosa
eating disorders
Journal
The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
11
10
2022
received:
22
08
2022
accepted:
01
11
2022
pubmed:
15
11
2022
medline:
21
1
2023
entrez:
14
11
2022
Statut:
ppublish
Résumé
Investigate medical morbidity and risk of general hospital admission for patients with concurrent coronavirus disease 2019 (COVID-19) and anorexia nervosa (AN) who have not received severe acute respiratory syndrome coronavirus 2 vaccination. United Kingdom eating disorders clinicians contributed to a database of patients with an eating disorder and COVID-19. We used this to investigate demography, symptoms, hospitalization, treatment, and outcomes for those with AN. We describe data for 49 patients (median age 21.5 years [interquartile range 17.0-33.5], 46 female) including 36 adults and 13 under-18-year-olds. Three (6.1% [95% confidence interval 1.3%-17.9]) were admitted to a general hospital. For this sample, the expected age-standardized hospital admission rate per COVID-19 case (based on the general population of England) was 2.6% and therefore not significantly different to the hospitalization rate we observed. Three (including two of those admitted to hospital) contracted pneumonia. One had severe pneumonia and was admitted to an intensive care unit. No deaths or use of mechanical ventilation were recorded. To our knowledge, this represents the first study investigating medical morbidity or frequency of hospitalization for patients with COVID-19 and AN. We did not find evidence that patients with AN are at increased risk of severe COVID-19. Medical morbidity and risk of hospitalization associated with concurrent COVID-19 and anorexia nervosa (AN) had not, to our knowledge, been studied before. We used a database of patients with eating disorders and COVID-19 (to which United Kingdom clinicians had contributed) to investigate presentation, treatment, outcomes, and COVID-19 severity for those with AN and COVID-19. We did not find evidence that patients with AN are at increased risk of severe COVID-19.
Identifiants
pubmed: 36374243
doi: 10.1002/eat.23851
pmc: PMC10100157
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-287Informations de copyright
© 2022 The Authors. International Journal of Eating Disorders published by Wiley Periodicals LLC.
Références
Ir J Psychol Med. 2020 Sep;37(3):187-191
pubmed: 32434615
Int J Eat Disord. 2016 Jun;49(6):542-52
pubmed: 26875554
J Eat Disord. 2021 Jan 20;9(1):15
pubmed: 33472682
J Psychiatr Res. 2018 Aug;103:252-264
pubmed: 29906710
Immunology. 1998 Aug;94(4):543-51
pubmed: 9767443
Int J Eat Disord. 2023 Jan;56(1):282-287
pubmed: 36374243
Neurosci Biobehav Rev. 2021 Sep;128:592-620
pubmed: 34089764
Lancet Child Adolesc Health. 2020 Aug;4(8):634-640
pubmed: 32540024
Postgrad Med J. 1978 Jun;54(632):395-9
pubmed: 683907
J Clin Med. 2019 Nov 08;8(11):
pubmed: 31717370
Acta Neuropsychiatr. 2008 Jun;20(3):117-28
pubmed: 26951035
Clin Microbiol Infect. 2018 Jan;24(1):24-28
pubmed: 28232162
J Adolesc Health. 2015 Jan;56(1):121-5
pubmed: 25530605
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Am J Clin Nutr. 1982 May;35(5):973-80
pubmed: 6805290